Free Trial

Creative Medical Technology (CELZ) Competitors

Creative Medical Technology logo
$3.48 -0.03 (-0.85%)
Closing price 03:59 PM Eastern
Extended Trading
$3.60 +0.12 (+3.30%)
As of 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CELZ vs. MURA, MRSN, SNTI, RANI, DYAI, XFOR, JATT, RENB, OKUR, and ITRM

Should you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Mural Oncology (MURA), Mersana Therapeutics (MRSN), Senti Biosciences (SNTI), Rani Therapeutics (RANI), Dyadic International (DYAI), X4 Pharmaceuticals (XFOR), JATT Acquisition (JATT), Renovaro (RENB), OnKure Therapeutics (OKUR), and Iterum Therapeutics (ITRM). These companies are all part of the "pharmaceutical products" industry.

Creative Medical Technology vs. Its Competitors

Mural Oncology (NASDAQ:MURA) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

In the previous week, Mural Oncology's average media sentiment score of 0.00 equaled Creative Medical Technology'saverage media sentiment score.

Company Overall Sentiment
Mural Oncology Neutral
Creative Medical Technology Neutral

Mural Oncology has a beta of 3, indicating that its stock price is 200% more volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500.

Creative Medical Technology has higher revenue and earnings than Mural Oncology. Creative Medical Technology is trading at a lower price-to-earnings ratio than Mural Oncology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mural OncologyN/AN/A-$128.51M-$8.59-0.24
Creative Medical Technology$10K897.84-$5.49M-$3.18-1.09

Creative Medical Technology's return on equity of -82.99% beat Mural Oncology's return on equity.

Company Net Margins Return on Equity Return on Assets
Mural OncologyN/A -107.76% -87.57%
Creative Medical Technology N/A -82.99%-79.49%

Mural Oncology currently has a consensus price target of $12.00, indicating a potential upside of 479.71%. Given Mural Oncology's stronger consensus rating and higher probable upside, equities research analysts clearly believe Mural Oncology is more favorable than Creative Medical Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mural Oncology
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Creative Medical Technology
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

80.2% of Mural Oncology shares are owned by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are owned by institutional investors. 2.2% of Mural Oncology shares are owned by company insiders. Comparatively, 1.8% of Creative Medical Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Mural Oncology beats Creative Medical Technology on 7 of the 12 factors compared between the two stocks.

Get Creative Medical Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CELZ vs. The Competition

MetricCreative Medical TechnologyMED IndustryMedical SectorNASDAQ Exchange
Market Cap$9.06M$3.16B$5.80B$10.46B
Dividend YieldN/A2.36%5.61%4.57%
P/E Ratio-1.0921.03348.5626.86
Price / Sales897.84447.99549.90125.65
Price / CashN/A44.8326.0131.15
Price / Book0.969.8315.536.50
Net Income-$5.49M-$52.82M$3.29B$271.25M
7 Day PerformanceN/A3.47%200.87%3.69%
1 Month Performance9.09%5.35%184.38%8.07%
1 Year Performance11.54%13.26%325.51%29.65%

Creative Medical Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELZ
Creative Medical Technology
0.783 of 5 stars
$3.48
-0.9%
N/A+12.5%$9.06M$10K-1.095
MURA
Mural Oncology
2.7244 of 5 stars
$2.07
flat
$12.00
+479.7%
-38.5%$35.86MN/A-0.24119
MRSN
Mersana Therapeutics
4.0165 of 5 stars
$7.21
+0.6%
$56.60
+685.0%
-86.6%$35.78M$40.50M-0.49150
SNTI
Senti Biosciences
2.5467 of 5 stars
$1.39
+2.2%
$8.50
+511.5%
-57.1%$35.58M$2.56M-0.164
RANI
Rani Therapeutics
2.4937 of 5 stars
$0.50
+2.3%
$7.33
+1,369.6%
-78.0%$35.06M$1.03M-0.55110Gap Down
DYAI
Dyadic International
2.6507 of 5 stars
$0.99
+2.6%
$6.00
+505.6%
-14.4%$34.94M$3.49M-5.217News Coverage
XFOR
X4 Pharmaceuticals
4.2874 of 5 stars
$3.21
+7.4%
$34.17
+964.4%
-85.1%$34.11M$2.56M-0.2280
JATT
JATT Acquisition
N/A$1.92
-4.0%
N/A-55.2%$33.12MN/A0.003High Trading Volume
RENB
Renovaro
0.4424 of 5 stars
$0.18
-4.0%
N/A-66.3%$32.82MN/A-0.2420Upcoming Earnings
High Trading Volume
OKUR
OnKure Therapeutics
2.9948 of 5 stars
$2.37
-0.8%
$32.33
+1,264.3%
N/A$32.34MN/A-0.49N/A
ITRM
Iterum Therapeutics
2.5022 of 5 stars
$0.68
-0.7%
$9.00
+1,224.9%
-36.5%$32.26MN/A-0.8010

Related Companies and Tools


This page (NASDAQ:CELZ) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners